February 4, 2009 - Dilon Technologies released of two new collimators: the Slant15 Collimator for breast imaging and the Low Energy High-Resolution (LEHR) Collimator, which are attachment options for the Dilon 6800 Gamma Camera that help to optimize imaging for the respective applications.

The Slant15 Collimator is a 15-degree slant parallel-hole collimator that reportedly minimizes the dead space along the edge of the detector, allowing better visualization of the chest wall in breast imaging. Uses include: breast imaging; sentinel node imaging; thyroid imaging; and parathyroid imaging.

LEHR collimator is a high-resolution collimator for general nuclear medicine applications. Uses include thyroid imaging, parathyroid imaging, sentinel node imaging, spot bone imaging, gall bladder ejection and pediatric imaging studies.

The release of these new collimators is part of Dilon expansion of breast imaging and general nuclear applications for the Dilon 6800 Gamma.

For more information: www.dilon.com


Related Content

News | Women's Health

Dec. 1, 2025 — ScreenPoint Medical has completed a commercial agreement making its Transpara breast-imaging AI portfolio ...

Time December 03, 2025
arrow
News | RSNA 2025

Dec. 2, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, will present 14 studies at RSNA ...

Time December 02, 2025
arrow
News | Women's Health

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the ...

Time December 02, 2025
arrow
News | Artificial Intelligence

Nov. 25, 2025 – Medical imaging AI company Avicenna.AI has announced a strategic partnership with Ferrum, an AI ...

Time November 25, 2025
arrow
News | Ultrasound Imaging

Nov. 12, 2025 — GE HealthCare and DeepHealth, Inc., a wholly owned subsidiary of RadNet, Inc., have announced their ...

Time November 20, 2025
arrow
News | Artificial Intelligence

Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara ...

Time November 07, 2025
arrow
News | RSNA 2025

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar ...

Time November 04, 2025
arrow
News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
News | Breast Imaging

Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has ...

Time October 28, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
Subscribe Now